Nykode Therapeutics
NYKD.OL
#9012
Rank
A$0.10 B
Marketcap
$0.33
Share price
-44.08%
Change (1 day)
-87.10%
Change (1 year)

Nykode Therapeutics (NYKD.OL) - Cash on Hand

Cash on Hand as of June 2024 : A$0.20 Billion

According to Nykode Therapeutics's latest financial reports the company has A$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nykode Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.30 B-3.79%
2021-12-31A$0.31 B16.05%
2020-12-31A$0.27 B5193.38%
2019-12-31A$5.11 M89.05%
2018-12-31A$2.7 M-31%
2017-12-31A$3.92 M